{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T15:23:07Z","timestamp":1788967387679,"version":"build-2803163510"},"reference-count":60,"publisher":"Bentham Science Publishers Ltd.","issue":"1","funder":[{"DOI":"10.13039\/501100002725","name":"Amirkabir University of Technology","doi-asserted-by":"publisher","award":["GN2020"],"award-info":[{"award-number":["GN2020"]}],"id":[{"id":"10.13039\/501100002725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["PNT"],"published-print":{"date-parts":[[2022,2]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Acne is the pilosebaceous units' disorder. The most important cause of\nacne is the colonization of bacteria in the follicles. Among antibiotics, doxycycline hyclate kills a\nwide range of bacteria.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives:<\/jats:title>\n                    <jats:p>The study aims to prevent oral administration's side effects, overcome the barriers of\nconventional topical treatment, and improve the therapeutic effectiveness; this drug was loaded\ninto niosomal nanocarriers for topical application.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Doxycycline hyclate was loaded into four niosomal formulations prepared by the thinfilm\nhydration method with different percentages of constituents. Drug-containing niosomal systems\nwere evaluated for morphological properties via scanning electron microscopy, particle size,\ndrug entrapment efficiency, zeta potential, in vitro drug release, physical stability after 60 days, in\nvitro drug permeation through rat skin, in vitro drug deposition in rat skin, toxicity on human dermal\nfibroblasts (HDF) by MTT method after 72 hours, and antibacterial properties against the main\nacne-causing bacteria via antibiogram test.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>The best formulation had the appropriate particle size of 362.88 \u00b1 13.05 nm to target follicles,\nentrapment efficiency of 56.3 \u00b1 2.1%, the zeta potential of - 24.46\u00b11.39 mV, in vitro drug\nrelease of 54.93 \u00b1 1.99% after 32 hours, and the lowest permeation of the drug through the rat skin\namong all other formulations. Improved cell viability, increased antibacterial activity, and an approximately\nthree-fold increase in drug deposition were the optimal niosomal formulation features\nrelative to the free drug.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>This study demonstrated the ability of nano-niosomes containing doxycycline hyclate\nto treat skin acne compared with the free drug.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/2211738510666220224103406","type":"journal-article","created":{"date-parts":[[2022,2,25]],"date-time":"2022-02-25T00:10:49Z","timestamp":1645747849000},"page":"56-68","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Niosome-encapsulated Doxycycline Hyclate for Potentiation of Acne\nTherapy: Formulation and Characterization"],"prefix":"10.2174","volume":"10","author":[{"given":"Fatemeh","family":"Kashani-Asadi-Jafari","sequence":"first","affiliation":[{"name":"Department of Biomedical Engineering, Amirkabir University of Technology, Tehran 159163-4311, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afra","family":"Hadjizadeh","sequence":"additional","affiliation":[{"name":"Department of Biomedical Engineering, Amirkabir University of Technology, Tehran 159163-4311, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"9197","DOI":"10.2147\/IJN.S237508","volume":"15","author":"Mancuso A.","year":"2020","unstructured":"Mancuso A.; Cristiano M.C.; Fresta M.; Paolino D.; The challenge of nanovesicles for selective topical delivery for acne treatment: Enhancing absorption whilst avoiding toxicity. Int J Nanomed 2020,15,9197-9210","journal-title":"Int J Nanomed"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.clindermatol.2009.03.012","volume":"28","author":"Dessinioti C.","year":"2010","unstructured":"Dessinioti C.; Katsambas A.D.; The role of Propionibacterium acnes in acne pathogenesis: Facts and controversies. Clin Dermatol 2010,28(1),2-7","journal-title":"Clin Dermatol"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1590\/s1984-82502016000300018","volume":"52","author":"Ruela A.L.M.","year":"2016","unstructured":"Ruela A.L.M.; Perissinato A.G.; Lino M.E de S.; Mudrik P.S.; Pereira G.R.; Evaluation of skin absorption of drugs from topical and transdermal formulations. Braz J Pharm Sci 2016,52(3),527-544","journal-title":"Braz J Pharm Sci"},{"key":"ref=4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2020.119140","volume":"579","author":"Patel R.","year":"2020","unstructured":"Patel R.; Prabhu P.; Nanocarriers as versatile delivery systems for effective management of acne. Int J Pharm 2020,579","journal-title":"Int J Pharm"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"267","DOI":"10.4103\/2229-5178.120635","volume":"4","author":"Gupta S.","year":"2013","unstructured":"Gupta S.; Bansal R.; Gupta S.; Jindal N.; Jindal A.; Nanocarriers and nanoparticles for skin care and dermatological treatments. Indian Dermatol Online J 2013,4(4),267-272","journal-title":"Indian Dermatol Online J"},{"key":"ref=6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2020.105638","volume":"158","author":"G\u00fcng\u00f6r S.","year":"2021","unstructured":"G\u00fcng\u00f6r S.; Kahraman E.; Nanocarriers mediated cutaneous drug delivery. Eur J Pharm Sci 2021,158","journal-title":"Eur J Pharm Sci"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s12951-018-0392-8","volume":"16","author":"Patra J.K.","year":"2018","unstructured":"Patra J.K.; Das G.; Fraceto L.F.; Nano based drug delivery systems:\nRecent developments and future prospects. J Nanobiotechnol 2018,16(1),71"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1517\/17425247.5.6.665","volume":"5","author":"Castro G.A.","year":"2008","unstructured":"Castro G.A.; Ferreira L.A.M.; Novel vesicular and particulate drug delivery systems for topical treatment of acne. Expert Opin Drug Deliv 2008,5(6),665-679","journal-title":"Expert Opin Drug Deliv"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1208\/s12249-016-0579-y","volume":"18","author":"Moghassemi S.","year":"2017","unstructured":"Moghassemi S.; Hadjizadeh A.; Hakamivala A.; Omidfar K.; Growth factor-loaded nano-niosomal gel formulation and characterization. AAPS PharmSciTech 2017,18(1),34-41","journal-title":"AAPS PharmSciTech"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1080\/00914037.2017.1332623","volume":"67","author":"Amoabediny G.","year":"2018","unstructured":"Amoabediny G.; Haghiralsadat F.; Naderinezhad S.; Overview of preparation methods of polymeric and lipid-based (niosome, solid lipid, liposome) nanoparticles: A comprehensive review. Int J Polym Mater 2018,67(6),383-400","journal-title":"Int J Polym Mater"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.ejpb.2019.08.015","volume":"144","author":"Chen S.","year":"2019","unstructured":"Chen S.; Hanning S.; Falconer J.; Locke M.; Wen J.; Recent advances in non-ionic surfactant vesicles (niosomes): Fabrication, characterization, pharmaceutical and cosmetic applications. Eur J Pharm Biopharm 2019,144,18-39","journal-title":"Eur J Pharm Biopharm"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.cis.2012.08.002","volume":"183-184","author":"Mahale N.B.","year":"2012","unstructured":"Mahale N.B.; Thakkar P.D.; Mali R.G.; Walunj D.R.; Chaudhari S.R.; Niosomes: Novel sustained release nonionic stable vesicular systems - An overview. Adv Colloid Interface Sci 2012,183-184,46-54","journal-title":"Adv Colloid Interface Sci"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"98","DOI":"10.3109\/21691401.2014.916715","volume":"44","author":"Garg T.","year":"2016","unstructured":"Garg T.; Current nanotechnological approaches for an effective delivery of bio-active drug molecules in the treatment of acne. Artif Cells Nanomed Biotechnol 2016,44(1),98-105","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"2823","DOI":"10.2174\/1381612821666150428143730","volume":"21","author":"Kakadia P.G.","year":"2015","unstructured":"Kakadia P.G.; Conway B.R.; Lipid nanoparticles for dermal drug delivery. Curr Pharm Des 2015,21(20),2823-2829","journal-title":"Curr Pharm Des"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1128\/MMBR.65.2.232-260.2001","volume":"65","author":"Chopra I.","year":"2001","unstructured":"Chopra I.; Roberts M.; Tetracycline antibiotics: Mode of action, applications, molecular biology, and epidemiology of bacterial resistance. Microbiol Mol Biol Rev 2001,65(2),232-260","journal-title":"Microbiol Mol Biol Rev"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1016\/j.xphs.2016.01.017","volume":"105","author":"Goodarzi N.","year":"2016","unstructured":"Goodarzi N.; Barazesh Morgani A.; Abrahamsson B.; Biowaiver monographs for immediate release solid oral dosage forms: Ribavirin. J Pharm Sci 2016,105(4),1362-1369","journal-title":"J Pharm Sci"},{"key":"ref=17","first-page":"553","volume":"73","author":"Peyriere H.","year":"2018","unstructured":"Peyriere H.; Makinson A.; Marchandin H.; Reynes J.; Doxycycline in the management of sexually transmitted infections. J Antimicrob Chemother 2018,73(3),553-563","journal-title":"J Antimicrob Chemother"},{"key":"ref=18","first-page":"19","volume":"8","author":"Rosso J.Q.D.","year":"2015","unstructured":"Rosso J.Q.D.; Oral doxycycline in the management of acne vulgaris: Current perspectives on clinical use and recent findings with a new double-scored small tablet formulation. J Clin Aesthet Dermatol 2015,8(5),19-26","journal-title":"J Clin Aesthet Dermatol"},{"key":"ref=19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2020.101715","volume":"57","author":"Akbarzadeh I.","year":"2020","unstructured":"Akbarzadeh I.; Yaraki M.T.; Bourbour M.; Optimized doxycycline-loaded niosomal formulation for treatment of infection-associated prostate cancer: An in-vitro investigation. J Drug Deliv Sci Technol 2020,57","journal-title":"J Drug Deliv Sci Technol"},{"key":"ref=20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2019.06.022","volume":"567","author":"Gugleva V.","year":"2019","unstructured":"Gugleva V.; Titeva S.; Rangelov S.; Momekova D.; Design and in vitro evaluation of doxycycline hyclate niosomes as a potential ocular delivery system. Int J Pharm 2019,567","journal-title":"Int J Pharm"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1016\/j.nano.2015.07.010","volume":"11","author":"Dwivedi A.","year":"2015","unstructured":"Dwivedi A.; Mazumder A.; du Plessis L.; du Preez J.L.; Haynes R.K.; du Plessis J.; In vitro anti-cancer effects of artemisone nano-vesicular formulations on melanoma cells. Nanomed 2015,11(8),2041-2050","journal-title":"Nanomed"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1081\/DDC-100100348","volume":"26","author":"Ruckmani K.","year":"2000","unstructured":"Ruckmani K.; Jayakar B.; Ghosal S.K.; Nonionic surfactant vesicles (niosomes) of cytarabine hydrochloride for effective treatment of leukemias: Encapsulation, storage, and in vitro release. Drug Dev Ind Pharm 2000,26(2),217-222","journal-title":"Drug Dev Ind Pharm"},{"key":"ref=23","first-page":"283","volume":"67","author":"Dora C.P.","year":"2010","unstructured":"Dora C.P.; Singh S.K.; Kumar S.; Datusalia A.K.; Deep A.; Development and characterization of nanoparticles of glibenclamide by solvent displacement method. Acta Pol Pharm 2010,67(3),283-290","journal-title":"Acta Pol Pharm"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1039\/D0MA00298D","volume":"1","author":"Shah A.","year":"2020","unstructured":"Shah A.; Boldhane S.; Pawar A.; Bothiraja C.; Advanced development of a non-ionic surfactant and cholesterol material based niosomal gel formulation for the topical delivery of anti-acne drugs. Mater Adv 2020,1(6),1763-1774","journal-title":"Mater Adv"},{"key":"ref=25","first-page":"93","volume":"43","author":"Plessis J.","year":"1992","unstructured":"Plessis J.; Egbaria K.; Weiner N.; Influence of formulation factors on the deposition of liposomal components into the different strata of the skin. J Soc Cosmet Chem 1992,43,93-100","journal-title":"J Soc Cosmet Chem"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1021\/acsbiomaterials.8b00068","volume":"4","author":"Ganguly P.","year":"2018","unstructured":"Ganguly P.; Breen A.; Pillai S.C.; Toxicity of nanomaterials: Exposure, pathways, assessment, and recent advances. ACS Biomater Sci Eng 2018,4(7),2237-2275","journal-title":"ACS Biomater Sci Eng"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.2147\/IJN.S156412","volume":"13","author":"Hashim I.I.A.","year":"2018","unstructured":"Hashim I.I.A.; El-Magd N.F.A.; El-Sheakh A.R.; Hamed M.F.; El-Gawad A.E.H.A.; Pivotal role of Acitretin nanovesicular gel for effective treatment of psoriasis: Ex vivo-in vivo evaluation study. Int J Nanomed 2018,13,1059-1079","journal-title":"Int J Nanomed"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.dsi.2015.12.004","volume":"34","author":"Kumar B.","year":"2016","unstructured":"Kumar B.; Pathak R.; Mary P.B.; Jha D.; Sardana K.; Gautam H.K.; New insights into acne pathogenesis: Exploring the role of acne-associated microbial populations. Zhonghua Pifuke Yixue Zazhi 2016,34(2),67-73","journal-title":"Zhonghua Pifuke Yixue Zazhi"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.jconrel.2014.04.015","volume":"185","author":"Moghassemi S.","year":"2014","unstructured":"Moghassemi S.; Hadjizadeh A.; Nano-niosomes as nanoscale drug delivery systems: An illustrated review. J Control Release 2014,185,22-36","journal-title":"J Control Release"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s40005-016-0249-9","volume":"46","author":"Khan R.","year":"2016","unstructured":"Khan R.; Irchhaiya R.; Niosomes: A potential tool for novel drug delivery. J Pharm Investig 2016,46(3),195-204","journal-title":"J Pharm Investig"},{"key":"ref=31","first-page":"121","volume":"66","author":"Agarwal S.","year":"2004","unstructured":"Agarwal S.; Bakshi V.; Vitta P.; Raghuram A.P.; Pandey S.; Udupa N.; Effect of cholesterol content and surfactant HLB on vesicle properties of niosomes. Indian J Pharm Sci 2004,66,121-123","journal-title":"Indian J Pharm Sci"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.apsb.2011.09.002","volume":"1","author":"Kumar G.P.","year":"2011","unstructured":"Kumar G.P.; Rajeshwarrao P.; Nonionic surfactant vesicular systems for effective drug delivery \u2014 An overview. Acta Pharm Sin B 2011,1(4),208-219","journal-title":"Acta Pharm Sin B"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S0378-5173(03)00183-2","volume":"258","author":"Verma D.D.","year":"2003","unstructured":"Verma D.D.; Verma S.; Blume G.; Fahr A.; Particle size of liposomes influences dermal delivery of substances into skin. Int J Pharm 2003,258(1-2),141-151","journal-title":"Int J Pharm"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.ijpharm.2005.05.009","volume":"300","author":"Nasseri B.","year":"2005","unstructured":"Nasseri B.; Effect of cholesterol and temperature on the elastic properties of niosomal membranes. Int J Pharm 2005,300(1-2),95-101","journal-title":"Int J Pharm"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"227","DOI":"10.4103\/0973-8398.76752","volume":"4","author":"Essa E.","year":"2010","unstructured":"Essa E.; Effect of formulation and processing variables on the particle size of sorbitan monopalmitate niosomes. Asian J Pharm 2010,4(4),227-233","journal-title":"Asian J Pharm"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s40005-014-0121-8","volume":"44","author":"Abdelkader H.","year":"2014","unstructured":"Abdelkader H.; Farghaly U.; Moharram H.; Effects of surfactant type and cholesterol level on niosomes physical properties and in vivo ocular performance using timolol maleate as a model drug. J Pharm Investig 2014,44(5),329-337","journal-title":"J Pharm Investig"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1080\/08982100500364131","volume":"15","author":"Lee S.C.","year":"2005","unstructured":"Lee S.C.; Lee K.E.; Kim J.J.; Lim S.H.; The effect of cholesterol in the liposome bilayer on the stabilization of incorporated retinol. J Liposome Res 2005,15(3-4),157-166","journal-title":"J Liposome Res"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1017\/S1431927613000536","volume":"19","author":"Reis C.P.","year":"2013","unstructured":"Reis C.P.; Gomes A.; Rijo P.; Development and evaluation of a novel topical treatment for acne with azelaic acid-loaded nanoparticles. Microsc Microanal 2013,19(5),1141-1150","journal-title":"Microsc Microanal"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S0378-5173(02)00301-0","volume":"244","author":"Hao Y.","year":"2002","unstructured":"Hao Y.; Zhao F.; Li N.; Yang Y.; Li K.; Studies on a high encapsulation of colchicine by a niosome system. Int J Pharm 2002,244(1-2),73-80","journal-title":"Int J Pharm"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1208\/s12249-016-0487-1","volume":"18","author":"Moghassemi S.","year":"2017","unstructured":"Moghassemi S.; Hadjizadeh A.; Omidfar K.; Formulation and characterization of bovine serum albumin-loaded niosome. AAPS PharmSciTech 2017,18(1),27-33","journal-title":"AAPS PharmSciTech"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0378-5173(94)90228-3","volume":"105","author":"Yoshioka T.","year":"1994","unstructured":"Yoshioka T.; Sternberg B.; Florence A.T.; Preparation and properties of vesicles (niosomes) of sorbitan monoesters (span 20, 40, 60 and 80) and a sorbitan triester (span 85). Int J Pharm 1994,105(1),1-6","journal-title":"Int J Pharm"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"490","DOI":"10.3390\/pharmaceutics11100490","volume":"11","author":"Latter G.","year":"2019","unstructured":"Latter G.; Grice J.E.; Mohammed Y.; Roberts M.S.; Benson H.A.E.; Targeted topical delivery of retinoids in the management of Acne vulgaris: Current formulations and novel delivery systems. Pharmaceutics 2019,11(10),490","journal-title":"Pharmaceutics"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1097\/00006534-198705000-00009","volume":"79","author":"Morykwas M.J.","year":"1987","unstructured":"Morykwas M.J.; Thornton J.W.; Bartlett R.H.; Zeta potential of synthetic and biological skin substitutes: Effects on initial adherence. Plast Reconstr Surg 1987,79(5),732-739","journal-title":"Plast Reconstr Surg"},{"key":"ref=44","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2020.119183","volume":"580","author":"Zhang Y.","year":"2020","unstructured":"Zhang Y.; Jing Q.; Hu H.; Sodium dodecyl sulfate improved stability and transdermal delivery of salidroside-encapsulated niosomes via effects on zeta potential. Int J Pharm 2020,580","journal-title":"Int J Pharm"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/S0378-5173(98)00092-1","volume":"168","author":"Freitas C.","year":"1998","unstructured":"Freitas C.; M\u00fcller R.H.; Effect of light and temperature on zeta potential and physical stability in Solid Lipid Nanoparticle (SLN\u00ae) dispersions. Int J Pharm 1998,168(2),221-229","journal-title":"Int J Pharm"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1002\/anie.200802453","volume":"48","author":"Soussan E.","year":"2009","unstructured":"Soussan E.; Cassel S.; Blanzat M.; Rico-Lattes I.; Drug delivery by soft matter: Matrix and vesicular carriers. Angew Chem Int Ed Engl 2009,48(2),274-288","journal-title":"Angew Chem Int Ed Engl"},{"key":"ref=47","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2019.118580","volume":"569","author":"Ghafelehbashi R.","year":"2019","unstructured":"Ghafelehbashi R.; Akbarzadeh I.; Yaraki M.T.; Lajevardi A.; Fatemizadeh M.; Saremi L.H.; Preparation, physicochemical properties, in vitro evaluation and release behavior of cephalexin-loaded niosomes. Int J Pharm 2019,569","journal-title":"Int J Pharm"},{"key":"ref=48","first-page":"217","volume":"67","author":"Dash S.","year":"2010","unstructured":"Dash S.; Murthy P.N.; Nath L.; Chowdhury P.; Kinetic modeling on drug release from controlled drug delivery systems. Acta Pol Pharm 2010,67(3),217-223","journal-title":"Acta Pol Pharm"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1517\/17425241003602259","volume":"7","author":"Fu Y.","year":"2010","unstructured":"Fu Y.; Kao W.J.; Drug release kinetics and transport mechanisms of non-degradable and degradable polymeric delivery systems. Expert Opin Drug Deliv 2010,7(4),429-444","journal-title":"Expert Opin Drug Deliv"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/0168-3659(87)90035-6","volume":"5","author":"Ritger P.L.","year":"1987","unstructured":"Ritger P.L.; Peppas N.A.; A simple equation for description of solute release II. Fickian and anomalous release from swellable devices. J Control Release 1987,5(1),37-42","journal-title":"J Control Release"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.ijpharm.2016.12.018","volume":"517","author":"Kassem A.A.","year":"2017","unstructured":"Kassem A.A.; El-Alim S.H.A.; Asfour M.H.; Enhancement of 8-methoxypsoralen topical delivery via nanosized niosomal vesicles: Formulation development, in vitro and in vivo evaluation of skin deposition. Int J Pharm 2017,517(1-2),256-268","journal-title":"Int J Pharm"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"120","DOI":"10.3109\/10717544.2013.779332","volume":"20","author":"Hasan A.A.","year":"2013","unstructured":"Hasan A.A.; Madkor H.; Wageh S.; Formulation and evaluation of metformin hydrochloride-loaded niosomes as controlled release drug delivery system. Drug Deliv 2013,20(3-4),120-126","journal-title":"Drug Deliv"},{"key":"ref=53","first-page":"404","volume":"19","author":"Pardakhty A.","year":"2011","unstructured":"Pardakhty A.; Moazeni E.; Varshosaz J.; Hajhashemi V.; Najafabadi A.R.; Pharmacokinetic study of niosome-loaded insulin in diabetic rats. Daru 2011,19(6),404-411","journal-title":"Daru"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/S1773-2247(12)50059-6","volume":"22","author":"Ibrahim M.M.","year":"2012","unstructured":"Ibrahim M.M.; Shehata T.M.; The enhancement of transdermal permeability of water soluble drug by niosome-emulgel combination. J Drug Deliv Sci Technol 2012,22(4),353-359","journal-title":"J Drug Deliv Sci Technol"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1016\/j.addr.2007.07.004","volume":"59","author":"Godin B.","year":"2007","unstructured":"Godin B.; Touitou E.; Transdermal skin delivery: Predictions for humans from in vivo, ex vivo and animal models. Adv Drug Deliv Rev 2007,59(11),1152-1161","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.2174\/1567201815666180619105419","volume":"15","author":"Aziz D.E.","year":"2018","unstructured":"Aziz D.E.; Abdelbary A.A.; Elassasy A.I.; Implementing central composite design for developing transdermal diacerein-loaded niosomes: Ex vivo permeation and in vivo deposition. Curr Drug Deliv 2018,15(9),1330-1342","journal-title":"Curr Drug Deliv"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/S0378-5173(01)00627-5","volume":"219","author":"Fang J.Y.","year":"2001","unstructured":"Fang J.Y.; Hong C.T.; Chiu W.T.; Wang Y.Y.; Effect of liposomes and niosomes on skin permeation of enoxacin. Int J Pharm 2001,219(1-2),61-72","journal-title":"Int J Pharm"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.ijpharm.2015.03.020","volume":"485","author":"Abdelbary A.A.","year":"2015","unstructured":"Abdelbary A.A.; AbouGhaly M.H.H.; Design and optimization of topical methotrexate loaded niosomes for enhanced management of psoriasis: Application of Box-Behnken design, in-vitro evaluation and in-vivo skin deposition study. Int J Pharm 2015,485(1-2),235-243","journal-title":"Int J Pharm"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"35","DOI":"10.22270\/jddt.v8i5.1886","volume":"8","author":"Kaur D.","year":"2018","unstructured":"Kaur D.; Kumar S.; Niosomes: Present scenario and future aspects. J Drug Deliv Ther 2018,8(5),35-43","journal-title":"J Drug Deliv Ther"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.colsurfb.2011.05.018","volume":"87","author":"Mehta S.K.","year":"2011","unstructured":"Mehta S.K.; Jindal N.; Kaur G.; Quantitative investigation, stability and in vitro release studies of anti-TB drugs in Triton niosomes. Colloids Surf B 2011,87(1),173-179","journal-title":"Colloids Surf B"}],"container-title":["Pharmaceutical Nanotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/2211738510666220224103406","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/201395\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/2211738510666220224103406","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T23:40:14Z","timestamp":1692920414000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/201395\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/2211738510666220224103406","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.09.28.462256","asserted-by":"object"}]},"ISSN":["2211-7385"],"issn-type":[{"value":"2211-7385","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2021-12-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-01-07","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-01-12","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-04-20","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}